Atherectomy Devices Market Size, Share & Trends Analysis, and Segment Forecasts, 2019 - 2026

Table of Content

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.2 Market Segmentation
3.2.1 Analysis
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing prevelance of target diseases
3.3.1.2 Preference to minimally invasive procedures
3.3.2 Market restraint analysis
3.3.2.1 Lack of level 1 evidence for atherectomy
3.3.2.2 Lack of technical training for the procedures
3.3.3 Industry opportunities
3.4 Penetration & Growth Prospect Mapping
3.4.1 Penetration & growth prospect mapping analysis
3.5 Business Environment Analysis Tools
3.5.1 Porter’s five forces analysis
3.5.2 Pestel analysis
3.5.3 Major deals & strategic alliances analysis
3.5.3.1 Mergers & acquisitions and joint ventures
3.5.3.2 Licensing & partnerships and technology collaborations
Chapter 4 Atherectomy Devices Market: Type Analysis
4.1 Atherectomy Devices Type Market Share Analysis, 2018 & 2026
4.2 Atherectomy Devices Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Type Segment
4.3.1 Directional atherectomy
4.3.1.1 Directional atherectomy devices market, 2015 - 2026 (USD Million)
4.3.2 Rotational atherectomy
4.3.2.1 Rotational atherectomy devices market, 2015 - 2026 (USD Million)
4.3.3 Orbital atherectomy
4.3.3.1 Orbital atherectomy devices market, 2015 - 2026 (USD Million)
4.3.4 Laser atherectomy
4.3.4.1 Laser atherectomy devices market, 2015 - 2026 (USD Million)
Chapter 5 Atherectomy Devices Market: Regional Analysis
5.1 Atherectomy Devices Regional Market Share Analysis, 2018 & 2026
5.2 Atherectomy Devices-Regional Market: Segment Dashboard
5.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
5.4 List of Players at Regional Level
5.4.1 North America
5.4.2 Europe
5.4.3 Asia Pacific
5.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1 North America
5.5.2 Europe
5.5.3 Asia Pacific
5.5.4 Latin America
5.5.5 MEA
5.6 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
5.6.1 North America
5.6.1.1 North America Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.1.2 U.S.
5.6.1.2.1 Regulatory & reimbursement scenario
5.6.1.2.2 U.S. Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.1.3 Canada
5.6.1.3.1 Regulatory & reimbursement scenario
5.6.1.3.2 Canada Atherectomy Devices market, 2015- 2026 (USD Million)
5.6.2 Europe
5.6.2.1 Europe Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.2.2 UK
5.6.2.2.1 Regulatory & reimbursement scenario
5.6.2.2.2 UK Atherectomy Devices market, 2015- 2026 (USD Million)
5.6.2.3 Germany
5.6.2.3.1 Regulatory & reimbursement scenario
5.6.2.3.2 Germany Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.2.4 France
5.6.2.4.1 Regulatory & reimbursement scenario
5.6.2.4.2 France Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.2.5 Italy
5.6.2.5.1 Regulatory & reimbursement scenario
5.6.2.5.2 Italy Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.3 Asia Pacific
5.6.3.1 Asia Pacific Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.3.2 Japan
5.6.3.2.1 Regulatory & reimbursement scenario
5.6.3.2.2 Japan Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.3.3 China
5.6.3.3.1 Regulatory & reimbursement scenario
5.6.3.3.2 China Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.4 Latin America
5.6.4.1 Latin America Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.4.2 Brazil
5.6.4.2.1 Regulatory & reimbursement scenario
5.6.4.2.2 Brazil Atherectomy Devices market, 2015 - 2026 (USD Million)
5.6.5 Middle East and Africa
5.6.5.1 MEA Atherectomy Devices market, 2015- 2026 (USD Million)
5.6.5.2 South Africa
5.6.5.2.1 Regulatory & reimbursement scenario
5.6.5.2.2 South Africa Atherectomy Devices market, 2015 - 2026 (USD Million)
Chapter 6 Competitive Analysis
6.1 Recent developments & impact analysis, by key market participants
6.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3 Vendor Landscape
6.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
6.4 Company Profiles
6.4.1 Boston Scientific Corporation
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Product benchmarking
6.4.1.4 Strategic initiatives
6.4.1.5 SWOT analysis
6.4.2 Cardiovascular Systems Inc.
6.4.2.1 Company overview
6.4.2.2 Financial performance
6.4.2.3 Product benchmarking
6.4.2.4 Strategic initiatives
6.4.2.5 SWOT analysis
6.4.3 Medtronic plc.
6.4.3.1 Company overview
6.4.3.2 Financial performance
6.4.3.3 Product benchmarking
6.4.3.4 Strategic initiatives
6.4.3.5 SWOT analysis
6.4.4 Spectranetics
6.4.4.1 Company overview
6.4.4.2 Financial performance
6.4.4.3 Product benchmarking
6.4.4.4 Strategic initiatives
6.4.4.5 SWOT analysis
6.4.5 VOLCANO CORPORATION
6.4.5.1 Company overview
6.4.5.2 Financial performance
6.4.5.3 Product benchmarking
6.4.5.4 Strategic initiatives
6.4.5.5 SWOT analysis
6.4.6 Avinger Inc.
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Product benchmarking
6.4.6.4 Strategic initiatives
6.4.6.5 SWOT analysis
6.4.7 KONINKLIJKE PHILIPS N.V
6.4.7.1 Company overview
6.4.7.2 Financial performance
6.4.7.3 Product benchmarking
6.4.7.4 Strategic initiatives
6.4.7.5 SWOT analysis
6.4.8 Straub Medical AG
6.4.8.1 Company overview
6.4.8.2 Product benchmarking
6.4.8.3 Financial performance
6.4.8.4 Strategic initiatives
6.4.8.5 SWOT Analysis
6.4.9 ST. JUDE MEDICAL
6.4.9.1 Company overview
6.4.9.2 Product benchmarking
6.4.9.3 Financial performance
6.4.9.4 Strategic initiatives
6.4.9.5 SWOT analysis
6.4.10 Bard Peripheral Vascular
6.4.10.1 Company overview
6.4.10.2 Product benchmarking
6.4.10.3 Financial performance
6.4.10.4 Strategic initiatives
6.4.10.5.SWOT Analysis
6.4.11 CARDINAL HEALTH (CORDIS)
6.4.11.1 Company overview
6.4.11.2 Product benchmarking
6.4.11.3 Financial performance
6.4.11.4 Strategic initiatives
6.4.11.5.SWOT Analysis
6.4.12 TERUMO MEDICAL CORPORATION
6.4.12.1 Company overview
6.4.12.2 Product benchmarking
6.4.12.3 Financial performance
6.4.12.4 Strategic initiatives
6.4.12.5.SWOT Analysis
Chapter 7 Recommendations